全球artificial intelligence (AI) in drug discovery marketsize is expected to reach USD 4.05 billion by 2028 according to a new study by Polaris Market Research. The report“药物发现的人工智能市场份额，规模，趋势，行业分析报告，通过治疗区域（肿瘤，神经退行性疾病，心血管疾病，代谢疾病，传染病，其他）;通过申请;按地区;分部预测，2021 - 2028“详细了解当前市场动态，并提供未来市场增长分析。
基于治疗区域，药物发现市场的全球人工智能（AI）被分段为肿瘤，神经变性疾病，心血管疾病，代谢疾病，传染病等。在2020年，肿瘤学分部占最大的收入份额。人工智能在癌症预诊断中起着重要作用。癌症治疗因人与人而异，个性化医学发挥了重要作用。
人工智能（AI）平台旨在确定遗传突变，帮助肿瘤学家设计有效的治疗计划。在这条线上，一家以瑞士的公司，索菲亚遗传学开发了一个AI平台，通过检测遗传变异和设计个性化癌症治疗计划，有助于识别肿瘤。
However, the infectious disease segment of artificial intelligence (AI) in drug discovery industry is projected to witness a lucrative growth rate over the study period. The increasing adoption of artificial intelligence (AI) platforms in infectious diseases to identify key infection patterns. A positive scenario for the segment is also illustrated by key partnerships and collaborations in the market for artificial intelligence (AI) in drug discovery.
有问题吗？在通过单击下面的链接，请在购买此报告之前请求示例或进行查询：//m.nkkjrh.com/idulty-analysis/ai-in-drug-discovery-market/request-for-sample.
例如，基于人工智能（AI）的药物发现公司，存在于与Scripps Research达成协议，以识别Covid-19抗病毒疗法。在同一地面上，谷歌的深度公司也在致力于人工智能（AI）平台alphafold。该产品旨在提供有关涉及SARS和Covid-19诊断的几种蛋白质的信息。
Market participants such as IBM Watson, Alphabet (DeepMind), Exscientia, GNS Healthcare, Insitro, BioSymetrics, Euretos, Berg Health, Benevolent AI, Atomwise, and Cyclica. are some of the key players operating in the global market. The companies in the artificial intelligence (AI) industry are involved in collaborations and partnerships with artificial intelligence (AI) platform providers to revolutionize medical treatment.
In this direction, in January 2021, the U.S.-based provider of biomarkers-based therapy, Nucleai signed a collaboration agreement with Debiopharm, pharma company pioneering in drug development. According to the agreement the latter will use Nucleai’s artificial intelligence (AI) platform for its pipeline oncology drug candidates.
Polaris Market Research has segmented the artificial intelligence in drug discovery market report on the basis of application, therapeutic area, and region:
药物发现中的人工智能，申请前景（收入 - 百万，2016 - 2028）
- 药物优化和重新展示
- Preclinical testing
- Others
药物发现中的人工智能，治疗区域前景（收入 - 百万，2016 - 2028）
- Oncology
- Neurodegenerative Diseases
- Cardiovascular Disease
- 代谢疾病
- 传染病
- Others
药物发现中的人工智能，区域前景（收入 - 百万，2016 - 2028）
- North America
- U.S.
- 加拿大
- 欧洲
- 法国
- 德国
- UK
- 意大利
- 西班牙
- Netherlands
- Austria
- Asia Pacific
- China
- 印度
- Japan
- 马来西亚
- Australia
- Indonesia
- Central & South America
- 墨西哥
- 巴西
- Argentina
- Middle East & Africa
- UAE
- Saudi Arabia
- 以色列
- South Africa